Angel Discussions: Investing in Medical Devices & Digital Health
Join Howard Edelman, Digital Health Angel Investor for a discussion on using regulatory class criteria as a key driver when looking at Angel investments in the Medical device industry.
VC and Angel Investor
Howard Edelman is a medical device executive accomplished in all aspects of medical product commercialization. Currently, Mr. Edelman is CEO of Tesa Medical, a developer of ACL graft tensioning systems and CEO of Advanced Resin Therapeutics, a developer of a broad-based drug delivery platform based on medical grade plant resins. Previously, Mr. Edelman was General Manager of Cothera, a division of United Orthopedic Group, a global orthopedic devices and patient services company. UOG acquired by Breg in 2014. Mr. Edelman advises a variety of medical device and biotech companies (iDentical, Karuna Labs, Watershed Medical, Pluto Medical, and Carbon Trainer). He is Chairman of the Medical Device and Digital Health screening committee of Life Science Angels and the EIR at the UCSF Innovation Ventures group.
Previously, Howard Edelman was the Founder and CEO of VitalWear, a leader in thermal and compression therapy systems. In 2009, VitalWear was named on the INC 500 list of fastest growing private companies and on the San Francisco Business Times Fast 100. Mr. Edelman has served in management roles at Johnson & Johnson, Zeiss, CooperVision, and Bio-Rad Laboratories and various startup companies in the Bay Area. Mr. Edelman sat on the Research Committee for the Juvenile Diabetes Research Foundation. Mr. Edelman holds a B.S. in Biomedical Engineering from Boston University.
|12:00 – 12:45 PST
|12:45 – 1:30 PST
For the last portion of our program, investors will have the opportunity to discuss issues face-to-face with our speaker. We hope that this will be a more meaningful, engaging, and dynamic experience for you. The Chair will continue to moderate this discussion.
During registration you have the opportunity to provide questions
you would like our guest speaker to answer.
Join our Email List to receive timely information about our investor programs and events in 2021.